Status:
COMPLETED
Reducing Sedentary Behaviour in Patients With Type II Diabetes
Lead Sponsor:
Western University, Canada
Collaborating Sponsors:
St. Joseph's Health Care London
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study will implement a prospective one-arm feasibility study. After an initial eligibility screening by the primary care provider during their intake appointment, new patients will be invited to p...
Detailed Description
Following pre-screening at their intake appointment, if appropriate for a DIGMA and eligible to participate, new patients to SJHC PCDSP will be invited to attend a DIGMA scheduled two-weeks post-intak...
Eligibility Criteria
Inclusion
- Participants, aged 18 years or older, will be eligible if they present diagnostic criteria according to the Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada for type 2 diabetes (diagnosed by any of the following criteria: glycated hemoglobin (A1C) ≥6.5%, fasting plasma glucose (FPG) ≥7.0 mmol/L, 2-hour plasma glucose (2hPG) in a 75 g oral glucose tolerance test (OGTT) ≥11.1 mmol/L, random PG ≥11.1 mmol/L) and would benefit from a DIGMA.
Exclusion
- Individuals with diabetes will be excluded if they are younger than 18 years, have significant illness, or an inability to communicate in English.
Key Trial Info
Start Date :
March 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 25 2019
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT03815955
Start Date
March 14 2019
End Date
April 25 2019
Last Update
October 1 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Western Ontario
London, Ontario, Canada, N6A 3K7
2
St. Joseph's Family Medical and Dental Centre
London, Ontario, Canada, N6G 1J1